"10.1371_journal.pone.0011409","plos one","2010-07-01T00:00:00Z","Jeroen J A van Kampen; Mariska L Reedijk; Peter C Burgers; Lennard J M Dekker; Nico G Hartwig; Ineke E van der Ende; Ronald de Groot; Albert D M E Osterhaus; David M Burger; Theo M Luider; Rob A Gruters","Department of Neurology, Erasmus MC, Rotterdam, The Netherlands; Department of Paediatrics, Erasmus MC â€“ Sophia, Rotterdam, The Netherlands; Department of Virology, Erasmus MC, Rotterdam, The Netherlands; Department of Internal Medicine, Erasmus MC, Rotterdam, The Netherlands; Department of Paediatrics, University Medical Centre Nijmegen, Nijmegen, The Netherlands; Department of Clinical Pharmacy, University Medical Centre Nijmegen, Nijmegen, The Netherlands","Conceived and designed the experiments: JJAvK RdG TML RG. Performed the experiments: JJAvK MLR LJMD. Analyzed the data: JJAvK MLR PCB LJMD DB TML RG. Contributed reagents/materials/analysis tools: JJAvK NGH IEvdE ADMEO DB TML. Wrote the paper: JJAvK PCB TML RG.","In this project (T4-212), GlaxoSmithKline is the commercial partner of the public-private-partnership Top Institute Pharma. GlaxoSmithKline was not involved in study design, collection, analysis and interpretation of the data, writing of the manuscript or the decision to publish the manuscript. GlaxoSmithKline was not involved in employment, consultancy, patents, and we did not use products in development or marketing products from GlaxoSmithKline in this project. We adhere to all the PLoS ONE policies on sharing data and materials.","2010","07","Jeroen J A van Kampen","JJAVK",11,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA
